The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.
about
A role for the androgen metabolite, 5alpha androstane 3beta, 17beta diol (3β-diol) in the regulation of the hypothalamo-pituitary-adrenal axisEpigenetics of early child developmentAntiglucocorticoid treatments for mood disordersAntiglucocorticoid treatments for mood disordersImpact of sleep and its disturbances on hypothalamo-pituitary-adrenal axis activityAntidepressants recruit new neurons to improve stress response regulationIs there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive DisorderTreatment-resistant Late-life Depression: Challenges and PerspectivesParaneoplastic syndromes in olfactory neuroblastomaSex and stress hormone influences on the expression and activity of brain-derived neurotrophic factor.Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: a systematic review and meta-analysisBiomarkers predicting antidepressant treatment response: how can we advance the field?Enhancement of stress resilience through histone deacetylase 6-mediated regulation of glucocorticoid receptor chaperone dynamics.Biochemical markers subtyping major depressive disorderPolymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatmentIncreased lead biomarker levels are associated with changes in hormonal response to stress in occupationally exposed male participantsNovel biochemical markers of psychosocial stress in womenLithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patientsPredictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trialDo premenopausal women with major depression have low bone mineral density? A 36-month prospective studyCan variation in hypothalamic-pituitary-adrenal (HPA)-axis activity explain the relationship between depression and cognition in bipolar patients?Escitalopram and neuroendocrine response in healthy first-degree relatives to depressed patients--a randomized placebo-controlled trialACTH and cortisol response to Dex/CRH testing in women with and without premenstrual dysphoria during GnRH agonist-induced hypogonadism and ovarian steroid replacement.Functional interactions between steroid hormones and neurotrophin BDNFGlucocorticoid receptor dysfunction: consequences for the pathophysiology and treatment of mood disorders.Cognitive modulation of endocrine responses to CRH stimulation in healthy subjects.Regulation of corticosteroid receptor gene expression in depression and antidepressant actionAnalysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion responseThe combined dexamethasone/CRH Test (DEX/CRH test) and prediction of acute treatment response in major depressionGlucocorticoid receptor deletion from the dorsal raphé nucleus of mice reduces dysphoria-like behavior and impairs hypothalamic-pituitary-adrenocortical axis feedback inhibitionPhysical Activity Modulates Common Neuroplasticity Substrates in Major Depressive and Bipolar Disorder.Sex differences in stress-related psychiatric disorders: neurobiological perspectives.Mindfulness and compassion-oriented practices at work reduce distress and enhance self-care of palliative care teams: a mixed-method evaluation of an "on the job" program.Prenatal alcohol exposure: fetal programming and later life vulnerability to stress, depression and anxiety disordersDNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression.Pathophysiology of depression: do we have any solid evidence of interest to clinicians?Increased glucocorticoid receptor expression and activity mediate the LPS resistance of SPRET/EI mice.Tolerability of the dexamethasone-corticotropin releasing hormone test in major depressive disorder.A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.The Hypothalamic-Pituitary-Adrenal Axis in Major Depressive Disorder: A Brief Primer for Primary Care Physicians
P2860
Q21131285-CDE835BA-63AF-4C3C-A4B5-0FAC17E1D0A8Q21558362-E4F3CB38-BB44-4670-BB91-864D89D38D28Q24187372-9F969134-F90B-4BD2-9D67-8C27D5D5EC2BQ24242845-6288C6AA-C89A-44DC-883F-524021267B83Q24613705-4C01CBA6-1C74-4552-B04E-3A13EC678B1EQ24634257-FB9C5C38-E9BC-4B03-8C71-0B53B37C1092Q26747511-B07AE982-92A1-4797-AF1B-DD2D4F28DC8AQ26783006-468AE1F5-AC2A-4F76-AB5E-10B79CFAC611Q26801128-5EBAF250-B954-4B39-BA98-42BCF4ED4456Q26866575-AEE40974-D3DB-4675-99C0-3637BCA41CE3Q27004411-59ADE0F4-A2B4-4787-9F1E-7FEA43685BA2Q27026147-9A8104B3-03DD-4CD7-AF92-7F8CD7387AEEQ27328366-2F09280B-B805-4B41-82FC-660B64F14D10Q28081652-9A7E2647-36FD-4332-8BC8-356167763496Q28295248-43B443D2-0A78-4620-A761-70B57E430D24Q28396714-2CE2B4C7-373C-4750-8A51-BA989E6C2683Q28474607-F8D0E88D-0F0A-4370-ABC4-8BB746357AFBQ28478124-27DAC694-99B5-4403-BA81-62B24B85BEEEQ28710054-8D1799B7-D52A-4998-A265-08EDACD83866Q28728705-D154BC54-62B7-4FF3-9391-2148B804805EQ28729989-AF12C345-D437-4134-994E-3F15AD1B5DCCQ28743211-2EB6BDB9-B251-4B14-BC9A-B4644B4B6D7DQ30419064-43D474E7-4241-4C59-B9CD-CDAEC51FC89AQ30475604-88FA8BFF-6E0E-4E3E-9A73-208F6570A7EBQ30477689-B556F977-CE1E-4DA7-A88B-2D51F375F672Q30493212-642EC4A0-C3E4-4D00-A8C3-1B23A11C3648Q30498987-A5BDABE3-5392-48A6-B156-84D62D6636B1Q31130220-A67886E3-D222-4EE2-804B-5E13CD7BE079Q33403748-BAC78993-1556-4ED9-92EC-261420483614Q33639063-4E728FA5-71D8-4B83-914D-17E03E2A86F5Q33655590-131296C3-1D9E-4E55-9A37-CFC37C70163EQ33864552-AFED295F-F469-4091-8FFA-6A835C32D601Q33883433-BF4F2205-E33B-4F89-A044-B35AA76D4214Q33919857-1FF394A4-8674-4C89-B57F-C86CF2B57EFFQ34017635-862A02C6-8F07-4637-906D-BBAAD3A1C129Q34145754-E038938A-A4B5-42A0-A37F-BFC2CBF2443DQ34155493-3458F249-6A73-4AF6-8C5E-885E03E8B001Q34180109-8F4D1E6D-A6B9-4C56-950A-CA4E3203DF5BQ34183522-777E370A-6AB3-4EF4-BB50-A32791DB01B4Q34304937-D59C0161-B6A5-4498-9370-551B40F0EFE5
P2860
The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.
@en
The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.
@nl
type
label
The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.
@en
The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.
@nl
prefLabel
The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.
@en
The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.
@nl
P2093
P1476
The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.
@en
P2093
Holsboer F
Yassouridis A
P304
P356
10.1016/0022-3956(94)90017-5
P577
1994-07-01T00:00:00Z